Log in to save to my catalogue

Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients wit...

Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients wit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2e1fbdbdc341498ebebba1f697824c23

Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis

About this item

Full title

Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis

Publisher

Cheshire: Springer Healthcare

Journal title

Dermatology and therapy, 2024-09, Vol.14 (9), p.2577-2589

Language

English

Formats

Publication information

Publisher

Cheshire: Springer Healthcare

More information

Scope and Contents

Contents

Introduction
Treating plaque psoriasis (PsO) with guselkumab (GUS) promotes skin clearance and is associated with improvements in health-related quality of life (HRQoL), anxiety, and depression. It is unclear whether improvements in patient-reported outcomes are due to resolution of skin symptoms or the direct result of GUS treatment.
Methods...

Alternative Titles

Full title

Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2e1fbdbdc341498ebebba1f697824c23

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2e1fbdbdc341498ebebba1f697824c23

Other Identifiers

ISSN

2193-8210

E-ISSN

2190-9172

DOI

10.1007/s13555-024-01250-9

How to access this item